The South Korean company, founded in 2022, offers a platform that monitors and analyzes vital signs like oxygen saturation and body temperature to support real-time patient monitoring and medical staff decision-making. Their AI-enabled solution is used in hospitals to analyze biosignal data of critically ill patients, helping with the diagnosis and prediction of serious diseases. HUINNO AIM provides artificial intelligence solutions specifically designed for the medical industry.